Support for HIV and HPV cancer prevention clinical trials in the Americas
Official title: DCP - Clinical Trials Regulatory & Monitoring Support for US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network
Funded at Leidos Biomedical Research, INC. · NIH-11219802 · Data updated 2026-11-12
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 28, 2024 |
| Project end | August 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $500,000 |
| NIH project number | 75N91019D00024-0-759102400011-25 |
| Project ID | NIH-11219802 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals at risk for HIV or HPV infections, particularly in the Caribbean and Latin American regions.
✕Less likely to help
Patients who are not at risk for HIV or HPV infections may not receive any benefit from this research.
What this research studies
This research focuses on providing regulatory and monitoring support for clinical trials aimed at preventing HIV and HPV-related cancers in the US, Latin America, and the Caribbean. The project involves creating development plans for vaccines and therapeutics, analyzing product development strategies, and ensuring compliance with regulatory standards. Patients may benefit from improved access to innovative treatments and preventive measures as these trials progress.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and therapies for preventing HIV and HPV-related cancers.
How similar studies have gone: Previous research has shown success in developing vaccines and therapeutics for HIV and HPV, indicating a promising approach in this area.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.